12:00 AM
 | 
Feb 14, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Mylotarg gemtuzumab zogamicin regulatory update

The FDA's Oncologic Drugs Advisory Committee will review on March 17 the partners' NDA for Mylotarg,...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >